Have a feature idea you'd love to see implemented?
Let us know!
OFIX Orthofix Medical Inc
Price (delayed)
$18.68
Market cap
$713.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.13
Enterprise value
$818.52M
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with
Highlights
The gross profit has increased by 22% year-on-year and by 2.9% since the previous quarter
The EPS has grown by 20% YoY
Orthofix Medical's debt has soared by 53% YoY
The equity has contracted by 15% YoY and by 3.7% from the previous quarter
Key stats
What are the main financial stats of OFIX
Market
Valuations
Earnings
Shares outstanding
38.21M
Market cap
$713.84M
Enterprise value
$818.52M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.36
Price to sales (P/S)
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.04
Revenue
$784.25M
EBIT
-$97M
EBITDA
-$38.97M
Free cash flow
-$46.03M
Per share
Balance sheet
Liquidity
EPS
-$3.13
Free cash flow per share
-$1.2
Book value per share
$13.78
Revenue per share
$20.38
TBVPS
$14.77
Total assets
$867.87M
Total liabilities
$341.95M
Debt
$137.24M
Equity
$525.92M
Working capital
$224.32M
Debt to equity
0.26
Current ratio
2.39
Quick ratio
0.97
Net debt/EBITDA
-2.69
Margins
Efficiency
Dividend
EBITDA margin
-5%
Gross margin
68%
Net margin
-15.2%
Operating margin
-11.7%
Return on assets
-13.3%
Return on equity
-21.2%
Return on invested capital
-18.3%
Return on capital employed
-13.7%
Return on sales
-12.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OFIX stock price
How has the Orthofix Medical stock price performed over time
Intraday
-1.01%
1 week
6.14%
1 month
15.31%
1 year
66.93%
YTD
38.58%
QTD
19.59%
Financial performance
How have Orthofix Medical's revenue and profit performed over time
Revenue
$784.25M
Gross profit
$533.67M
Operating income
-$91.46M
Net income
-$119.03M
Gross margin
68%
Net margin
-15.2%
The company's operating margin rose by 41% YoY and by 7% QoQ
The company's operating income rose by 31% YoY and by 6% QoQ
Orthofix Medical's net margin has increased by 25% YoY and by 2.6% from the previous quarter
The gross profit has increased by 22% year-on-year and by 2.9% since the previous quarter
Growth
What is Orthofix Medical's growth rate over time
Valuation
What is Orthofix Medical stock price valuation
P/E
N/A
P/B
1.36
P/S
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.04
The EPS has grown by 20% YoY
The stock's price to book (P/B) is 36% more than its last 4 quarters average of 1.0 but 9% less than its 5-year quarterly average of 1.5
The equity has contracted by 15% YoY and by 3.7% from the previous quarter
The price to sales (P/S) is 31% higher than the last 4 quarters average of 0.7 but 23% lower than the 5-year quarterly average of 1.2
The revenue is up by 17% year-on-year
Efficiency
How efficient is Orthofix Medical business performance
The ROIC has grown by 41% YoY and by 6% from the previous quarter
The ROS has grown by 36% YoY and by 7% from the previous quarter
OFIX's return on assets is up by 22% year-on-year
OFIX's ROE is up by 12% YoY but it is down by 2.4% QoQ
Dividends
What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OFIX.
Financial health
How did Orthofix Medical financials performed over time
The total assets is 154% greater than the total liabilities
The company's total liabilities rose by 18% YoY
The current ratio has contracted by 7% YoY and by 3.6% from the previous quarter
Orthofix Medical's debt is 74% less than its equity
OFIX's debt to equity has soared by 73% YoY and by 4% from the previous quarter
Orthofix Medical's debt has soared by 53% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.